Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Vanguard

Vanguard Health Care Index Fund Admiral Shares (VHCIX)

Ticker VHCIX · Index fund · · Holdings as of May 31, 2026

Expense ratio
0.09%$9/yr per $10k
5-yr return
+7.2%annualized
1-yr return
+2.7%as of Dec 2024
Net assets
$19.0Ball share classes
Holdings
407

Bottom line

Is VHCIX a good fund? The bottom line

VHCIX is the Admiral share class of Vanguard Health Care Index Fund, an index health care sector mutual fund from Vanguard.

It charges 0.09% — about $9 a year on every $10,000 invested, cheaper than 97% of health care sector funds we track.

It returned +2.7% over one year, +7.2% a year over five years, +8.8% a year over ten (as of Dec 31, 2024, per its prospectus).

With $19.0 billion in net assets and 407 holdings, its largest position is Eli Lilly & Co (14.0%) and the top 10 make up 51.9% of the portfolio.

The closest lower-cost alternative we found is XLV (0.08%, 94% top-holdings overlap).

What stands out

  • Low cost: cheaper than 97% of health care sector peers
  • 5-year return beat 88% of category peers
  • Broadly diversified (407 holdings)
  • No front-end sales load
  • Large and established ($19.0 billion)

What to watch

  • Concentrated: top 10 holdings are 51.9% of assets

Updated Nov 19, 2026

What VHCIX invests in

Vanguard Health Care ETF, an exchange-traded share class of Vanguard Health Care Index Fund (the Fund), seeks to track the performance of a benchmark index that measures the investment return of health care stocks.

The Fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50 (the Target Index), an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The GICS health care sector includes health care provider and services companies, companies that manufacture and distribute health care equipment and supplies, and health care technology companies. It also includes companies involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks that make up the Target Index. The Fund attempts to replicate the…

From the fund's prospectus (filed Jun 30, 2026).

VHCIX performance

Fund calendar-year total returns, 2015–2024 2015: +7.2%; 2016: −3.3%; 2017: +23.4%; 2018: +5.6%; 2019: +22.0%; 2020: +18.2%; 2021: +20.5%; 2022: −5.5%; 2023: +2.5%; 2024: +2.7% +7% 2015 −3% 2016 +23% 2017 +6% 2018 +22% 2019 +18% 2020 +21% 2021 −6% 2022 +2% 2023 +3% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
VHCIX+2.7%+7.2%+8.8%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2024

Full VHCIX performance history →

What VHCIX costs

On a $10,000 investment, VHCIX's 0.09% expense ratio costs about $9 a year. The prospectus estimates $115 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full VHCIX fee table →

VHCIX top 10 holdings

#Holding% of fund
1Eli Lilly & Co14.04%
2Johnson & Johnson8.47%
3AbbVie Inc6.09%
4UnitedHealth Group Inc5.45%
5Merck & Co Inc4.66%
6Thermo Fisher Scientific Inc2.93%
7Amgen Inc2.87%
8Gilead Sciences Inc2.64%
9Intuitive Surgical Inc2.38%
10Pfizer Inc2.35%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 51.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to VHCIX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%94% Compare
FidelityFHLC Fidelity MSCI Health Care Index ETF0.084%94% Compare
iSharesIYH iShares U.S. Healthcare ETF0.37%92% Compare
J.P. MorganJDOC JPMorgan Healthcare Leaders ETF0.65%61% Compare
SchwabSWHFX Schwab Health Care Fund0.8%75% Compare
T. Rowe PriceQAAGZX T. Rowe Price Health Sciences Portfolio0.86%79% Compare

More funds like VHCIX →

VHCIX FAQ

What is the expense ratio of VHCIX?
VHCIX's expense ratio is 0.09%, which works out to about $9 a year for every $10,000 invested. The prospectus estimates total costs of $115 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VHCIX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 97% of health care sector peers; 5-year return beat 88% of category peers; broadly diversified (407 holdings); no front-end sales load; large and established ($19.0 billion); concentrated: top 10 holdings are 51.9% of assets. This is general information, not personalized advice.
What does VHCIX hold?
VHCIX's largest holdings are Eli Lilly & Co (14.0%), Johnson & Johnson (8.5%), AbbVie Inc (6.1%), UnitedHealth Group Inc (5.4%), Merck & Co Inc (4.7%). It holds 407 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is VHCIX's 5-year return?
VHCIX returned +7.2% a year over the five years ending Dec 31, 2024, and +8.8% a year over ten years. Past performance does not guarantee future results.
Does VHCIX have a sales load?
No. VHCIX has no front-end sales charge.
Is there an ETF version of VHCIX?
Yes — VHT is the ETF share class of the same fund, so it holds the same portfolio. Its expense ratio is 0.09%.
Who manages VHCIX?
VHCIX is offered by Vanguard through Vanguard World Fund.